Why did Merck issue an unusual press release? It knows investors are hyperfocused on I-O data
admin 7th May 2018 Uncategorised 0Investor “conspiracy theories” are real in immuno-oncology, something Merck knows all too well. So well, in fact, that the company recently changed up its communications game to address investor fears directly.
More: Why did Merck issue an unusual press release? It knows investors are hyperfocused on I-O data
Source: fierce